According to Akebia Therapeutics's latest financial reports the company's current revenue (TTM ) is $0.22 Billion USD. In 2024 the company made a revenue of $0.16 Billion USD a decrease over the revenue in the year 2023 that were of $0.19 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.